STORY · FORSKNING_
GPT-5 cuts costs in cell-free protein synthesis by 40 percent
OpenAI and Ginkgo Bioworks have developed an autonomous laboratory combining GPT-5 with cloud-based automation. The system uses closed-loop experimentation to optimize cell-free protein synthesis and achieved a 40 percent cost reduction.
WHY IT MATTERS
This demonstrates AI's potential to accelerate biotech research and lower protein production costs. The results could significantly impact the development of pharmaceuticals, industrial enzymes, and other bio-based products.
SOURCES
MACHINE-GENERATED SUMMARY This summary is written by machine from the sources below. We sort and explain — but we are a way into the field, not the final word. Check the source when something matters to you.